Davies J, Sheppard K, Fletcher J
Inflammation. 1984 Dec;8(4):343-51. doi: 10.1007/BF00918211.
Human neutrophil cobalamin binding protein (NCBP) is located exclusively in the neutrophil secondary granules. The soluble stimuli formlymethionyl-leucyl-phenylalanine and the low-molecular-weight complement fragment C5a both promote the dose-dependent release of NCBP from cytochalasin B-treated neutrophils in vitro. The extracellular discharge of NCBP induced by higher secretagogue is inhibited by prior exposure of neutrophils to the corticosteroids hydrocortisone and methylprednisolone and the nonsteroidal antiinflammatory agents indomethacin and ibuprofen. The four antiinflammatory agents function as competitive antagonists of neutrophil secondary granule discharge with a site of action at or near the cell surface. These findings support the hypothesis that antiinflammatory agents prevent neutrophil activation in vitro by inhibition of stimulus-receptor coupling. The significance of these observations with regard to the in vivo actions of these agents remains uncertain, however.
人类中性粒细胞钴胺素结合蛋白(NCBP)仅位于中性粒细胞的次级颗粒中。可溶性刺激物甲硫氨酰-亮氨酰-苯丙氨酸和低分子量补体片段C5a在体外均能促进细胞松弛素B处理的中性粒细胞中NCBP的剂量依赖性释放。较高分泌刺激物诱导的NCBP细胞外释放可被中性粒细胞预先暴露于皮质类固醇氢化可的松和甲泼尼龙以及非甾体抗炎药吲哚美辛和布洛芬所抑制。这四种抗炎药作为中性粒细胞次级颗粒释放的竞争性拮抗剂,其作用位点在细胞表面或附近。这些发现支持了这样一种假说,即抗炎药通过抑制刺激-受体偶联在体外预防中性粒细胞活化。然而,这些观察结果对于这些药物体内作用的意义仍不确定。